Search Results

An Interview With Nadine Abi-Jaoudeh, MD, FSIR

Dr. Abi-Jaoudeh discusses her endeavors in the HCC trial landscape, research consensus panels with the SIR Foundation, tips for fostering DEI as an institutional leader, and more.

Applying Evidence in Interventional Oncology

By Nadine Abi-Jaoudeh, MD, and Julius Chapiro, MD

Disparities in IR Care for Pulmonary Embolism

By Nadine Abi-Jaoudeh, MD, FSIR; Khwaja Ahmed; and Joseph Breuer

Renal and Adrenal

Panelists: Raul Uppot, MD; Stephen Ho, MD, FRCPC; and Nadine Abi-Jaoudeh, MD

Commentary: Staying on Course

Obtaining the highest level of evidence in interventional oncology requires that we stay on course and strive for positive prospective randomized trials.

By Nadine Abi-Jaoudeh, MD

Building the Evidence on Embolization

Gaps in existing data, key trends in clinical study endpoints, the role of registries and potential drawbacks, and the importance of patient-centric endpoints.

With Nadine Abi-Jaoudeh, MD, FSIR

Novel Embolotherapy and Combination Therapy for Interventional Oncology

A discussion on the landscape of IO combination therapies, the future of radiogenomics, and the effect of center and operator volume on IO procedures.

With Nadine Abi-Jaoudeh, MD, FSIR, CCRP

Top Tips in Interventional Oncology

Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.

By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE

What Is the Most Exciting Advancement in Interventional Oncology?

Experts discuss the potential of pulsed electrical field ablation, histotripsy, robotics, transarterial microperfusion, minimally invasive fixation for musculoskeletal pain, thyroid ablative therapies, and systemic and immunotherapies to further the field of IO.

By Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Ripal Gandhi, MD, FSIR, FSVM; Alan Alper Sag, MD; Rahul A. Sheth, MD; and Amanda Smolock, MD, PhD

Liver-Directed Interventional Oncology: My Top 5 Technical Pearls

Experts provide their top technical tips for cTACE, portal vein embolization, drug-eluting embolic TACE, radiation segmentectomy, parenchyma-sparing Y-90 with flow diversion, challenging ablations, ablation of poorly visualized hepatic tumors, and treatment of parasitized extrahepatic arteries.

By Thierry de Baere, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Robert J. Lewandowski, MD; Edward Kim, MD, FSIR; Raul N. Uppot, MD; Amanda Smolock, MD, PhD; David S. Wang, MD, FSIR; and Daniel Sze, MD, PhD

Embolization: Expanding Evidence and Awareness

By Amy C. Taylor, MD, and Gregory Makris, MD, PhD, DIC, FRCR

Advancements Across Interventional Oncology

By Yilun Koethe, MD, RPVI, and Ripal Gandhi, MD, FSIR, FSVM

Enhancing Interventional Oncology

By Ripal T. Gandhi, MD, FSIR, FSVM, and David M. Liu, MD, FRCPC, FSIR

Embolization: Opportunities and Obstacles

By Kari J. Nelson, MD, and Patrick Haage, MD, PhD, MBA

Exploring the Why: Pivotal Case-Based Decisions

By Leigh Ann O’Banion, MD